TrialBlood2018
A phase 2 study of ruxolitinib in combination with azacitidine in patients with myelofibrosis.
Lucia Masarova et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
43 papers cite it
this papertrialcites it
TrialBlood2018
Lucia Masarova et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.